baber/WOPTO huggingface dataset:
Patent NZ-580426-A (NZ)
Title: A self-checkout kiosk system having a first antenna and RFID tag in a main housing and a second antenna and RFID tag in a remote housing
Inventor: DAILY MICHAEL A
IPC: G06Q30/00
Filed: 2008-04-23
Abstract: A self-checkout kiosk system is disclosed. The self-checkout kiosk system comprises a main housing including a first RF antenna and RFID reader and a remote housing including a second RF antenna and RFID reader. The main housing and remote housing have first and second non-metallic panels. The first RF antenna is positioned adjacent the first non-metallic panel to transmit a TX signal toward an RFID tag corresponding to an item and to receive a RX signal from the RFID tag and the first RFID reader is positioned in the main housing and is connected to the first RF antenna to detect an RFID tag using the RX signal. The second RF antenna is positioned adjacent to the second non-metallic panel to transmit a TX signal toward the RFID tag and to receive a RX signal from the RFID tag and the second RFID reader is positioned in the remote housing and connected to the second RF antenna to receive the RX signal from the RFID tag.
Patent NZ-587092-A (NZ)
Title: Method of making a baked snack base product and the snack base product produced thereby
Inventor: DYHIN ANDREW
IPC: A23L19/18
Filed: 2009-01-29
Abstract: Disclosed is a method of processing a starch-based material to provide an edible food, comprising: providing the starch-based material; forming the starch-based material into a sticky mash by mincing the starch based material, the starch-based material being cooked or substantially gelatinized; baking portions of the mash between an opposed pair of heated surfaces to obtain a baked product, wherein the mash sticks to the opposed pair of heated surfaces upon contact therewith to provide the product with a pore structure and a controlled ratio of voids to solids within the product, the mash being compressed under at least initial compression by the heated surfaces to a predetermined thickness, and the stickiness of the mash decreasing during the baking for removal of the product from the heated surfaces at a predetermined moisture level of the product; and removing the baked product from the heated surfaces.
Patent NZ-591929-A (NZ)
Title: Production of multi-compound titanium alloy powder via solid-state-reduction process
Inventor: LIANG JING
IPC: C22C1/05
Filed: 2009-10-01
Abstract: A process for the manufacture of multi-compound titanium alloy powder is disclosed, wherein the process includes the following steps: (a) homogenization annealing of TiO2 at about 1200 deg. C to about 1400 Deg. C for about 2 to about 5 hours, in an inert environment of argon;(b) crushing and screening the results of (a) to the required particle size, wherein the required particle size is selected to give a desired particle size of alloy powder;(c) mixing the result of (b) with alloying metal oxide and/or elemental metal powders and CaH2 and heating at a temperature below the melting point of the alloy (between about 1200 Deg. C and about 1300 Deg. C) for about 2 to about 6 hours; and(d) recovering the alloy powder.
Patent NZ-593544-A (NZ)
Title: A container for fluid
Inventor: TREACY LYNDON THOMAS
IPC: B65B1/06
Filed: 2009-12-18
Abstract: 593544 Disclosed is a storage container for fluid or liquid fuel that allows collection from an external drainage surface without spillage from the outlet spout. The container includes an interior for containing a fluid; an inlet in fluid communication with the interior for draining the fluid into the container when the container is in a prone condition. A collecting wall provides a catchment surface for collecting the fluid and for draining the fluid from an exterior of the container into the interior through the inlet to collect the fluid when the container is in the prone condition. An outlet is in fluid communication with the interior for draining the collected fluid from the container when the container is in a pouring condition, wherein the pouring condition is transverse the prone condition. A riser in the outlet arranged so as to be elevated at least partially above the inlet when the container is in the prone condition, and so as to be lowered at least partially below the inlet when the container is in the pouring condition. The container is moveable from the prone condition to a carrying condition, and the carrying condition is transverse the prone condition, wherein the inlet is positioned in the collecting wall so as to be elevated above the collected fluid when the container is in the prone condition and the fluid has been collected. The inlet is positioned proximate an edge of the catchment surface so as to be elevated above the collected fluid when: the fluid has been collected and the container is in the carrying condition; and the fluid has been collected and the container is in the pouring condition. The container includes a handle for moving the container from the prone condition to the carrying condition, wherein the inlet is positioned proximate the handle. The catchment surface includes a flow obstacle for slowing a flow of the fluid on the exterior of the container.
Patent NZ-595432-A (NZ)
Title: 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
Inventor: HUFNAGEL HEATHER RAE
IPC: A61K31/397
Filed: 2010-04-15
Abstract: 595432 Disclosed is a compound of formula (I), wherein the variables are defined herein, a process for the preparation of said compound, and the use of said compound in the treatment of a CCR2 mediated syndrome, disorder or disease, such as those associated with MCP-1 expression or overexpression. Specific examples of the compound include the following: N-({ 1-[4-amino-4-(3-methoxy-phenyl)-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide, N-({ 1-[4-(3-amino-phenyl)-4-hydroxy-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide, and N-({ 1-[4-(3-cyano-phenyl)-4-hydroxy-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide
Patent NZ-595592-A (NZ)
Title: A bioreactor construction with nested reactor elecments which are vertical or inclined at an angle
Inventor: MOHR MARTIN
IPC: C12M1/04
Filed: 2010-03-08
Abstract: 595592 Disclosed is a device for a photochemical process, such as a photocatalytic and/or a photosynthetic process for the cultivation and production or hydrocultivation of phototrophic micro-organisms. A bioreactor is provided, and a reaction medium in the form of an aqueous solution or a suspension is guided in the reactor in a meandering or convoluting manner. The reactor through which the reaction medium flows comprises at least one reactor element comprising two pipes or chambers connected at a bottom that are vertical or inclined at an angle. The reaction medium is both introduced into the reactor and released therefrom over an upper reaction medium surface without pressure and freely to the atmosphere, where as a result of hydrostatic pressure and level compensation, a flow of the reaction medium is produced through the at least one reactor element. The reactor and said pipes or chambers are arranged in a light conducting liquid. Both introduction and removal of the reaction medium into and from the reactor are carried out continuously in a continuous flow process. The pipes or chambers comprise a transparent or translucent material.
Patent NZ-600764-A (NZ)
Title: Methods for producing amino-substituted glycolipid compounds
Inventor: KJAERSGAARD LAURSEN ANNE KATHERINE
IPC: A23L29/10
Filed: 2011-01-20
Abstract: 600764 Disclosed are compounds of formula (I) wherein: a first group selected from R1, R2 and R3 is an amino- or N-acylamino hexose moiety, the amino or N-acylamino group being present in place of the hydroxyl group at the 2-position of the hexose moiety, the acyl moiety of the N- group having 1 to 6 carbon atoms, or an oligosaccharide chain comprising 2 to 4 monosaccharide moieties, at least one of which is an amino- or N-acylamino hexose moiety as defined above; a second group selected from R1, R2 and R3 is an alkanoyl group having 3 to 40 carbon atoms or an alkenoyl group having 3 to 40 carbon atoms and 1 to 5 double bonds; and a third group selected from R1, R2 and R3 is hydrogen. Representative compounds include 1-O-(2-amino-2-deoxy-?-D-glucopyranosyl)-3-n-decanoylglycerol, 1-O-(2-(acetylamino)-2-deoxy-?-D-glucopyranosyl)-3-n-decanoylglycerol and 1-O-(2-amino-2-deoxy-?-D-glucopyranosyl)-3-n-octadecanoylglycerol. Also disclosed is a method of preparing a compound of formula (I), wherein: a first group selected from R1, R2 and R3 is an amino- or N-acylamino monosaccharide moiety, the acyl moiety of the N-acylamino group having 1 to 6 carbon atoms, or an oligosaccharide chain comprising 2 to 4 monosaccharide moieties, at least one of which is an amino- or N-acylamino hexose moiety as defined above; a second group selected from R1, R2 and R3 is a saturated or unsaturated acyl group having 3 to 40 carbon atoms; and a third group selected from R1, R2 and R3 is hydrogen; the method comprising contacting a monoacylglycerol, the acyl moiety thereof being a saturated or unsaturated acyl group having 3 to 40 carbon atoms, or an activated derivative thereof, with a source of amino- or N-acylamino monosaccharide moiety, or an activated derivative thereof, and, if required, a source of unsubstituted monosaccharide moiety, or an activated derivative thereof, optionally in the presence of a suitable catalyst or activating agent.
Patent NZ-601509-A (NZ)
Title: Computer-aided method and system for guided teaching and learning
Inventor: HAU KIT KING KITTY
IPC: G09B5/06
Filed: 2006-10-13
Abstract: Disclosed is a system-aided adaptive teaching and learning method using teaching modes preloaded with multimedia data to implement a teaching and learning process. The method includes signing up at least one teacher for one or more students attending at least one adaptive teaching and learning session. The method also includes selecting a subject for teaching with pre-set data in the form of a plurality of question sets presentable in at least one of a plurality of multimedia formats. Each question set of the plurality of question sets is comprised of at least one question, a list of exclusive possible answers and a first data set including feedbacks related to the list of possible answers. The first data set is preloaded in a database by an administrator. The first data set is also loaded in an auxiliary system for helping said one or more students use different multimedia stimuli to understand the plurality of question sets more easily. The method also includes dynamically triggering an optional communication network linked to one or more terminals with input devices and obtaining ynamically one or more individual practice scores during at least one practice session of a subset of said one or more students. Student behaviour during the at least one practice session is then analysed for establishing an initial average ability level for the one or more students. This initial average ability level is then matched with a challenge level predetermined for a plurality of the teaching modes and at least one of the plurality of teaching modes is retrieved. The at least one of said plurality of teaching modes matches the initial average ability. The method further includes formulating a set of teaching data according to the initial average ability level; presenting the set of teaching data on the one or more terminals with input devices for conducting a teaching and learning process; and implementing a series of teaching and learning processes.
Patent NZ-601862-A (NZ)
Title: Isolated renal cells and uses thereof
Inventor: SHARON PRESNELL
IPC: A61K35/12
Filed: 2009-11-12
Abstract: Discloses an enriched human renal cell population depleted of a B1 cell population comprising large granular cells of the collecting duct and tubular system having a density of less than 1.045 g/ml, wherein the cell population consists essentially of an enriched B3 cell population comprising erythropoietin (EPO)-producing cells, glomerular cells and vascular cells and have a density between 1.052 g/ml and 1.063 g/ml and/or an enriched B4 cell population comprising erythropoietin (EPO)-producing cells, glomerular cells and vascular cells and have a density between 1.063 g/ml and 1.091 g/ml. Wherein the cell population may be used on an implantable construct for improving or treating kidney function and disease.
Patent NZ-603011-A (NZ)
Title: Methods for biofuel production
Inventor: MASCHMEYER THOMAS
IPC: C10L1/00
Filed: 2011-04-07
Abstract: Disclosed is a method for producing a biofuel, the method comprising: treating organic matter with an aqueous solvent and at least one additional catalyst selected from the group consisting of: an acid catalyst; a water-gas-shift catalyst; an alumino-silicate catalyst; a sulphide catalyst; and a base catalyst, wherein the organic matter and aqueous solvent is provided in the form of a slurry, and said treating is under conditions of continuous flow with a minimum volume-independent flow velocity of the slurry greater than the settling velocity of solid matter within the slurry; wherein the treating comprises: heating and pressurisation to a target temperature of between about 250°C and about 400°C, and to a target pressure of between about 100 bar and about 300 bar to produce the biofuel, treatment at the target temperature and pressure for a defined time period, and cooling and depressurisation of the slurry, and wherein: the at least one additional catalyst is added to the organic matter after heating to said temperature and after pressurising to said pressure, and prior to said depressurisation of the slurry, the biofuel is a bio-oil, and the organic matter is coal or lignocellulosic matter.
Patent NZ-613449-A (NZ)
Title: Agri-horticultural pest control compositions comprising 4-(3-butynyl)aminopyrimidine derivatives
Inventor: SAKAI MASAAKI
IPC: A01P7/00
Filed: 2011-12-27
Abstract: Disclosed herein is a pest control composition for agricultural or horticultural use comprising as the active ingredients; one or more 4-(3-butynyl)aminoquinazoline derivatives represented by general formula [I] wherein R4 taken together with R3 and two carbon atoms of the pyrimidine ring forms a benzene ring, together with one or more pest control compounds for agricultural or horticultural use selected from for example; chlorothalonil, chinomethionate, iminoctadine albesilate, triflumizol, tebuconazole, difenoconazole, triadimefon, fenpropimorph, azoxystrobin, pyraclostrobin, trifloxystrobin, kresoxim-methyl, cyflufenamid, penthiopyrad, flutianil, quinoxyfen, thiophanate-methyl, diflumetorim, acibenzolar-S-methyl, manzeb, cyazofamid, amisulbrom, cymoxanil, kresoxim-methyl, azoxystrobin, metalaxyl M, mandipropamid, benthiavalicarbisopropyl, dimethomorph, acephate, imidacloprid, tolfenpyrad, acrinathrin, flonicamid, and pyrifluquinazon. Also disclosed are methods of treating or preventing microbial infection or insect infestation in plants using these compositions.
Patent NZ-615692-A (NZ)
Title: Compositions and methods of use of phorbol esters
Inventor: CHANG RICHARD L
IPC: C07C69/03
Filed: 2008-01-30
Abstract: Disclosed is the use of 12-O-tetradecanoylphorbol-13-acetate (TPA / phorbol-12-myristate-13-acetate / PMA) of Formula II, or a pharmaceutically-acceptable salt, stereoisomer, enantiomer, solvate, hydrate, polymorph or prodrug thereof, in the manufacture of a medicament for the prevention or treatment of HIV infection in a mammalian subject. Also disclosed is the use of TPA, or a pharmaceutically-acceptable salt, stereoisomer, enantiomer, solvate, hydrate, polymorph or prodrug thereof and at least one secondary anti-retroviral or adjunctive therapeutic agent, in the manufacture of a medicament for the prevention or treatment of HIV infection in a mammalian subject. Further disclosed is the use of TPA, or a pharmaceutically acceptable salt, stereoisomer, enantiomer, solvate, hydrate, polymorph or prodrug thereof, in the manufacture of a medicament for reducing or treating one or more symptoms of HIV infection or AIDS in a mammalian subject. Additionally, the use of TPA, or a pharmaceutically-acceptable salt, stereoisomer, enantiomer, solvate, hydrate, polymorph or prodrug thereof and at least one secondary anti-retroviral or adjunctive therapeutic agent, in the manufacture of a medicament for reducing or treating one or more symptoms of HIV infection or AIDS in a mammalian subject is also disclosed. The use of TPA, or a pharmaceutically-acceptable salt, stereoisomer, enantiomer, solvate, hydrate, polymorph or prodrug thereof, in the manufacture of a medicament for increasing an immune response in a mammalian subject with HIV infection is also further disclosed.
Patent NZ-618492-A (NZ)
Title: Treatment of respiratory conditions
Inventor: KLASEK PAUL JAN
IPC: A61M16/16
Filed: 2009-05-28
Abstract: 618492 A device (102) provides respiratory treatment for SDB (including mild OSA) and other respiratory conditions. A flow generator warms and humidifies gas at controlled flow levels. For example, the device (102) delivers breathable gas to the upper airway at flow rates of about 10-35 Liters/minute. Levels of flow rate, temperature and/or humidification of the device may be automatically adjusted in response to the detection of SDB events. The device may also automatically deliver adjustments of any of the levels in accordance with detected phases of respiratory cycles. In some embodiments, the device automatically delivers distinct levels to either of the nares based on independent control of flow to each nare. A warm-up procedure controls temperature and humidity at a desired target during a ramp-up of flow to the set therapy level. A cool-down procedure controls temperature above the dewpoint to avoid condensation internal to the device and patient interface.
Patent NZ-628782-A (NZ)
Title: Ar image processing apparatus and method
Inventor: ITO KAZUHIKO
IPC: G06T19/00
Filed: 2012-10-31
Abstract: An AR image processing apparatus comprises a camera (1), a storage, an AR marker recognition based first AR analyser (3A), a natural feature tracking based second AR analyser (3B), a CG rendering unit (5) and a display unit (7). The camera (1) captures a first captured image of a scene in a first field of view which includes an AR marker and its surroundings and a second captured image of a scene in a second field of view which includes at least some of the surroundings which included in the first captured image. The storage stores an image data of a CG object. The AR marker recognition based first AR analyser (3A) obtains the first captured image, carries out an AR marker recognition process to find out an AR marker image from the first captured image and determine a position, posture, and scale of the AR marker image in a first view volume space defined in a first coordinate system of this first AR analyser (3A). The natural feature tracking based second AR analyser (3B) obtains the first captured image and data of the determined position, posture, and scale of the AR marker image in the first view volume space, calculates a position, posture, and scale of the AR marker in a second view volume space defined in a second coordinate system of the second AR analyser (3B) corresponding to a current position, center axis direction and field of view of the camera (1), obtains the second captured image, and carries out a natural feature tracking process between the first and the second captured images to determine a position, posture, and scale of the AR marker image in the second captured image in the second view volume space of the second AR analyser (3B). The CG rendering unit (5) reads out the image data of the CG object corresponding to the AR marker from the storage, reproduces an image of the CG object corresponding to the calculated position, posture, and scale in the second view volume space and composites the image of the CG object with the second captured image of the camera (1). The display unit (7) displays the composite image.
Patent NZ-701136-A (NZ)
Title: Mask system
Inventor: NG EVA
IPC: A61M16/06
Filed: 2009-02-27
Abstract: A mask system for a patient, the mask system comprising: a first cushion module, wherein the first cushion module comprises: - a first cushion of a first material, wherein the first cushion is adapted to in use form a seal with the patient’s face, and - a frame 1140 of a second material, said, second material being a more rigid material than said first material, wherein the frame 1140 at least partially defines a breathing chamber or cavity to receive the patient’s nose and mouth and provide air communication to the patient, and the frame 1140 having a frame-opening to facilitate the supply of pressurized breathable gas to the patient via the breathing chamber or cavity, and wherein the frame comprises a collar 1149 surrounding the frame-opening; and a shroud module 1120 including a plurality of fingers 1145(1) extending from a shroud opening of the shroud module 1120 and which are configured to in use engage with the collar 1149 of the frame 1140 in a snap fit to thereby releasably attach the frame 1140 and the shroud module 1120 together.
Patent NZ-701185-A (NZ)
Title: Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
Inventor: MENG CHARLES Q
IPC: C07D235/28
Filed: 2013-04-18
Abstract: The invention relates to oral, topical or injectable compositions for combating liver fluke parasites in mammals, comprising at least one benzimidazole derivative active agent. The invention may be used to eradicate and control liver fluke parasite infections and infestations in a mammal, where the compositions of the invention are administered to the mammal in need thereof.
Patent NZ-703310-A (NZ)
Title: Direct current meat carcass electrical stimulation assembly
Inventor: GIELNIAK IGOR
IPC: A22C9/00
Filed: 2014-06-03
Abstract: The assembly according to the invention consists of two pairs of relays (1) and (2) as well as (3) and (4), preferably SSR semiconductor relays. The relays of each pair operate with the opposite direct current potentials. Direct current with the voltage of 220 V to 400 V as well as the UN1 and UN2 control lines are connected to the clamps of the controlled relays. The operation of the relays is controlled by means of the controller (5), preferably a PLC programmable controller. The relays (1) and (3) are connected to the first UN4 electrode clamp, and the relays (2) and (4) to the second UN5 electrode clamp. The assembly operates in such a way that the PLC controller activates the relays (1) and (2) from the UN2 line, which simultaneously activate the flow of the direct current with the voltage of 220 V to 400 V and mutually opposite polarity. As a result of this, a difference of potentials appears on the UN4 and UN5 electrode clamps.
Patent NZ-721417-A (NZ)
Title: Processes for obtaining microbial oil from microbial cells
Inventor: LEININGER NEIL FRANCIS
IPC: A23D9/00
Filed: 2014-12-19
Abstract: The present invention relates to processes for obtaining a lipid from a cell by lysing the cell to form a lysed cell composition and obtaining the lipid from the demulsified lysed cell composition. The invention is also directed to a lipid prepared by the processes of the present invention. The invention is also directed to microbial lipids having a particular anisidine value, peroxide value, and/or phosphorus content.
Patent NZ-729942-A (NZ)
Title: Ventilation mask
Inventor: KANE DAVID
IPC: A61M16/00
Filed: 2015-08-07
Abstract: Disclosed is a nasal ventilation mask having separate ventilation, O2 and CO2 ports, with the latter to monitor end-tidal CO2 expulsion integrated into the mask in order to monitor end-tidal CO2 expelled orally. The invention addresses problems with anesthesia, CPR and ventilation masks requiring the capability for oxygen and other gases to be supplied effectively.